Literature DB >> 5767018

Neurofibrillary degeneration induced by vincristine therapy.

M L Shelanski, H Wiśniewski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5767018     DOI: 10.1001/archneur.1969.00480080099012

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  26 in total

1.  The effect of vinblastin and vincristin on single nerve fibres.

Authors:  D Mitolo-Chieppa
Journal:  Experientia       Date:  1977-03-15

2.  Intracytoplasmic eosinophilic inclusions in the neurons of the central nervous system.

Authors:  C E Peña; A Katoh
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

3.  Neurofibrillary degeneration in a case of quadriplegia and myoclonic movement.

Authors:  S Kuroda; S Otsuki; J Tateishi; A Hirano
Journal:  Acta Neuropathol       Date:  1979-02-15       Impact factor: 17.088

4.  Presence of neurofilament protein in Alzheimer's neurofibrillary tangles (ANT). An immunofluorescent study.

Authors:  T Ishii; S Haga; S Tokutake
Journal:  Acta Neuropathol       Date:  1979-11       Impact factor: 17.088

5.  Retinal changes induced by treatment with vincristine and vinblastine.

Authors:  H A Hansson
Journal:  Doc Ophthalmol       Date:  1972-04-15       Impact factor: 2.379

6.  The wobbler mouse mutant: an animal model of hereditary motor system disease.

Authors:  M T Bird; E Shuttleworth; A Koestner; J Reinglass
Journal:  Acta Neuropathol       Date:  1971       Impact factor: 17.088

7.  Giant axonal neuropathy--a unique case with segmental neurofilamentous masses.

Authors:  A K Asbury; M K Gale; S C Cox; J R Baringer; B O Berg
Journal:  Acta Neuropathol       Date:  1972       Impact factor: 17.088

8.  Correlation of the clinical neurotoxicity of the vinca alkaloids vincristine, vinblastine, and vindesine with their effects on cultured rat midbrain cells.

Authors:  K L King; G B Boder
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

9.  Ultrastructural observations on the vincristine-induced neuronal crystalloid inclusion in young rats.

Authors:  M Sato; K Miyoshi
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

10.  Acute encephalopathy associated with continuous vincristine sulfate combination therapy: case report.

Authors:  W Scheithauer; H Ludwig; E Maida
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.